University Of Maryland, Baltimore
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
2157GCCC:Phase 1 of Calaspargase Pegol-mknl w/ Cytarabine and Idarubicin in Newly Dx AML
- Conditions
- Interventions
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 6
- Registration Number
- NCT04953780
- Locations
- 🇺🇸
Greenebaum Cancer Center, University of Maryland Medical Systems, Baltimore, Maryland, United States
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
- Conditions
- Interventions
- First Posted Date
- 2021-07-01
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 150
- Registration Number
- NCT04946721
- Locations
- 🇺🇸
Geenebaum Cancer Center, University of Maryland Medical Center, Baltimore, Maryland, United States
Clinical Decision Support Tool for Vancomycin Dosing in Children
- Conditions
- Interventions
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 75
- Registration Number
- NCT04911270
- Locations
- 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Conditions
- Interventions
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 10
- Registration Number
- NCT04896658
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Impact of Counseling and Education on Opioid Consumption After ACL Reconstruction
- Conditions
- Interventions
- First Posted Date
- 2021-05-13
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 80
- Registration Number
- NCT04885231
- Locations
- 🇺🇸
University of Maryland Rehabilitation and Orthopaedic Institute, Baltimore, Maryland, United States
Heterotopic Ossification Prophylaxis
- Conditions
- Interventions
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 117
- Registration Number
- NCT04867278
- Locations
- 🇺🇸
University of Maryland, Shock Trauma Center, Baltimore, Maryland, United States
Malawi International Center of Excellence in Malaria Research School-based Cohort
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 786
- Registration Number
- NCT04858087
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
- First Posted Date
- 2021-04-20
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 259
- Registration Number
- NCT04851301
- Locations
- 🇺🇸
Luana Colloca, Baltimore, Maryland, United States
TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B
- Conditions
- Interventions
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT04843852
- Locations
- 🇺🇸
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States
🇺🇸Dr Sang V Tran Internal Medicine Practice, Falls Church, Virginia, United States
Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL
- Conditions
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 2
- Registration Number
- NCT04827745
- Locations
- 🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States